FDA approves HIV medication Lenacapavir, but it's costly

By Jonathan Lambert

Published June 24, 2025 at 4:14 AM EDT

A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.

Jonathan Lambert

Jonathan Lambert is a correspondent for NPR's Science Desk, where he covers the wonders of the natural world and how policy decisions can affect them.

See stories by Jonathan Lambert

Local journalism matters—and it’s at risk.

WKAR brings you trusted news, without barriers—no paywalls, no corporate spin. But now, federal funding that helps make it all possible is on the chopping block. Your support is more important than ever. Stand up for independent journalism in mid-Michigan—make your gift today.

DONATE